{"version":"1.0","provider_name":"South Africa Journal","provider_url":"https:\/\/southafricajournal.com","author_name":"sjadmin","author_url":"https:\/\/southafricajournal.com\/author\/sjadmin-s\/","title":"Parexel s\u2019appr\u00eate \u00e0 \u00eatre acquise par EQT Private Equity et Goldman Sachs Asset Management - South Africa Journal","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"PmRvjxOPS8\"><a href=\"https:\/\/southafricajournal.com\/parexel-sapprete-a-etre-acquise-par-eqt-private-equity-et-goldman-sachs-asset-management\/\">Parexel s\u2019appr\u00eate \u00e0 \u00eatre acquise par EQT Private Equity et Goldman Sachs Asset Management<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/southafricajournal.com\/parexel-sapprete-a-etre-acquise-par-eqt-private-equity-et-goldman-sachs-asset-management\/embed\/#?secret=PmRvjxOPS8\" width=\"600\" height=\"338\" title=\"&#8220;Parexel s\u2019appr\u00eate \u00e0 \u00eatre acquise par EQT Private Equity et Goldman Sachs Asset Management&#8221; &#8212; South Africa Journal\" data-secret=\"PmRvjxOPS8\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","description":"BOSTON et DURHAM, Caroline du Nord, 06 juill. 2021 (GLOBE NEWSWIRE) \u2014 Parexel, une organisation de recherche clinique (CRO) de premier plan \u00e0 l\u2019\u00e9chelle mondiale ax\u00e9e sur le d\u00e9veloppement et la fourniture de nouveaux traitements innovants pour faire progresser la sant\u00e9 des patients, a annonc\u00e9 aujourd\u2019hui l\u2019ex\u00e9cution d\u2019un accord de fusion d\u00e9finitif en vertu duquel [\u2026]"}